| Literature DB >> 33809662 |
Mohamed Kchaou1, Mohammed Alquraish1, Khaled Abuhasel1, Ahmad Abdullah2,3, Ashraf A Ali1.
Abstract
Over the last twenty years, researchers have focused on the potential applications of electrospinning, especially its scalability and versatility. Specifically, electrospun nanofiber scaffolds are considered an emergent technology and a promising approach that can be applied to biosensing, drug delivery, soft and hard tissue repair and regeneration, and wound healing. Several parameters control the functional scaffolds, such as fiber geometrical characteristics and alignment, architecture, etc. As it is based on nanotechnology, the concept of this approach has shown a strong evolution in terms of the forms of the materials used (aerogels, microspheres, etc.), the incorporated microorganisms used to treat diseases (cells, proteins, nuclei acids, etc.), and the manufacturing process in relation to the control of adhesion, proliferation, and differentiation of the mimetic nanofibers. However, several difficulties are still considered as huge challenges for scientists to overcome in relation to scaffolds design and properties (hydrophilicity, biodegradability, and biocompatibility) but also in relation to transferring biological nanofibers products into practical industrial use by way of a highly efficient bio-solution. In this article, the authors review current progress in the materials and processes used by the electrospinning technique to develop novel fibrous scaffolds with suitable design and that more closely mimic structure. A specific interest will be given to the use of this approach as an emergent technology for the treatment of bacteria and viruses such as COVID-19.Entities:
Keywords: COVID-19; bio-solution; electrospinning technique; innovative process; nanofiber scaffolds; new biotechnology applications
Year: 2021 PMID: 33809662 PMCID: PMC8002202 DOI: 10.3390/polym13060916
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Most important applications of the electrospun nanofibrous scaffolds in the last decade.
| Application | Polymer and Solvent Used | Product Characteristics | Ref. |
|---|---|---|---|
| Cosmetic mask | A siliceous sponge spicules (SSS) and polylactic acid (PLA). | A nanofiber composite (PLA/SSS) of 50–450-nm with enhanced thermal and mechanical properties; a slight enhancement in human foreskin fibroblast cell proliferation; a decent cytocompatibility; and antibacterial | [ |
| A gelatin solution prepared in ethanol extracted from Crude Carissa Carandas fruits (CCE) and incorporating acetic acid. | A smooth and continuous gelatin fibers mats (GFM) with an average diameter of 235.69 ± 10.45 nm. could be obtained with the optimal conditions of 30% ( | [ | |
| Anionic surfactants added to a natural biopolymer of galacturonic acid (PGuA) to enable its electrospinning to nanofibers. | Small spindled fibers of 2 to 10 μm length and 287 to 997 nm diameter. Large continuous fibers could be produced when an amount of 10 to 30% of high molecular weight PVA is used. | [ | |
| Drug Delivery | A poly(vinylpyrrolidone)/PVP electrospun to encapsulate β-carotene dissolved in ethanol. | PVP/β-carotene composite nanofibers of 176 to 306 nm average diameter were able to protect the β-carotene properties | [ |
| A blend of poly (ε-caprolactone) and poly (ethylene oxide) (PCL/PEO) incorporating a nanosized hydroxyapatite (n-HA) to carry curcumin. | A nanofiber material with slow release rate of curcumin and with a high cytotoxicity against breast cancer cell line | [ | |
| Chitosan/pullulan carried by a shell of polylactic acid (PLA) | A nanofiber with improved thermal properties and rapid dissolving capability in water. | [ | |
| Tissue engineering | A platelet-derived growth factor (PDGF-BB) contained within a shell of polylactic acid (PLA) and encapsulated within nanofibers | A 3D scaffolding nanofibers with microporous structure, acceptable mechanical properties and high cell compatibility. | [ |
| Crystalline cellulose (NCC) in a matrix of cellulose acetate (CA) polymer. | a bio-tissues of nanofibers with uniform diameter, moderate thermal properties and improved mechanical properties of 30 MPa tensile strength and 1.597 MPa module of elasticity. | [ | |
| A blend of poly(ε-caprolactone), poly(ethylene glycol), poly(ε-caprolactone) (PCEC) along with polylactide (PLA). | A biodegradable polylactide (PLA)/PCEC fibrous membranes compatible with bone tissues. | [ | |
| Cancer therapy | A poly(ε-caprolactone) (PCL) | A scaffolding system of long nanofibers to carry breast cancer therapy | [ |
| Wound dressing | A zein/Graphene oxide (GO) blend. The GO is loaded by | A nanofiber composite with enhanced mechanical properties and improved release profile. | [ |
| Gene delivery | A biopolymer incorporating nano-hydroxyapatite (nHAp) modified with linear polyethylenimine (LPEI), and poly(ε-caprolactone) (PCL). | A homogeneous and cohesive composite with structural characteristics, swelling and degradation behavior dependent on the size and amount of the included inorganic particles. | [ |
| Filter media. | A poly(ε-caprolactone) (PCL) | Nanofibers (NF) of average diameters of 180 and 234 nm with improved bioprotective activity and filtration efficiency | [ |